4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Viromed Medical AG (VME) operates in the Medical Devices industry and is headquartered in Rellingen, Germany with about 17 employees. Its market capitalization is roughly €100 million. In the fiscal year ended 2025-12-31, VME reported €5M in revenue and €1M in net income.
Viromed Medical AG engages in the development, manufacture, and distribution of medical products in Germany and internationally. The company offers ViroCAP, an application in dermatology and wound treatment; and PulmoPlas for the treatment of severe respiratory infections.
Interactive charts & full statements → Open the VME valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | €5M | €1M | €0M | €0M |
| Gross Profit | €2M | (€0M) | — | — |
| Operating Income (EBIT) | (€1M) | (€4M) | (€0M) | (€0M) |
| Net Income | €1M | (€3M) | (€0M) | (€0M) |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | €14M | €13M | €20M | €20M | — |
| Total Liabilities | €3M | €4M | €0M | €0M | — |
EUR; €M / €B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VME viewer.
About TickerBase · Data methodology & sources · Privacy · Terms